Niacin therapy unhelpful, occasionally harmful, study says
A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.
Cardiology
Mar 09, 2013 |
4 / 5 (1) |
0
Study shows mirabegron effective and well tolerated for overactive bladder
In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with ...
Diseases, Conditions, Syndromes
Mar 04, 2013 |
not rated yet |
0
Multivitamins may enhance mood and energy, new study says
(Medical Xpress)—A daily multivitamin supplement may enhance mood and energy, according to new research conducted at Swinburne University of Technology.
Health
Mar 04, 2013 |
4 / 5 (2) |
1
FDA approves drug for older women experiencing painful sex
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug to treat postmenopausal women who experience pain during sex, the agency announced Tuesday.
Medications
Feb 26, 2013 |
not rated yet |
0
Immune intervention reduces beta-cell death in type 1 diabetes
(HealthDay)—Patients recently diagnosed with type 1 diabetes have greater death of pancreatic β-cells compared with patients with long-standing diabetes, which can be reduced by treatment with teplizumab, ...
Diabetes
Feb 26, 2013 |
not rated yet |
0
FDA expands approval of Bayer cancer drug (Update)
The U.S. Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that do not respond to other treatments.
Medications
Feb 25, 2013 |
not rated yet |
0
New blood thinner beats older drug for vein clots
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
Medications
Feb 20, 2013 |
4 / 5 (1) |
0
|
Naltrexone linked to reduction in pain in fibromyalgia
(HealthDay)—Low-dose naltrexone treatment is associated with significant reductions in pain in patients with fibromyalgia, according to a study published in the February issue of Arthritis & Rheumatism.
Diseases, Conditions, Syndromes
Feb 12, 2013 |
3.5 / 5 (2) |
0
High doses of saw palmetto don't impact serum PSA
(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research ...
Cancer
Feb 08, 2013 |
not rated yet |
0
Rivaroxaban found noninferior to enoxaparin in acutely ill
(HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
Natural products could be as effective as synthetic drugs, although the odds are low
In a first-ever comprehensive study of 124 natural product combinations, a team of researchers from the National University of Singapore (NUS) and Tsinghua University, led by Professor Chen Yu Zong from the Department of ...
Medications
Feb 07, 2013 |
not rated yet |
0
Corticorelin acetate has steroid-sparing effect in brain cancer
(HealthDay)—Corticorelin acetate (CrA) administration to patients with peritumoral brain edema (PBE) allows the reduction of steroid doses and is associated with reduced incidence and severity of steroid-induced ...
Cancer
Feb 06, 2013 |
4 / 5 (1) |
0
When it comes to food aphrodisiacs, expert says look for nutrition at first bite rather than love
It's been said that food is the language of love. If so, can certain foods—or aphrodisiacs—promote romantic feelings or sexual desire?
Health
Feb 06, 2013 |
5 / 5 (1) |
0
Corticosteroid injection, physiotherapy do not provide significant improvement for 'tennis elbow'
Among patients with chronic unilateral lateral epicondylalgia ("tennis elbow"), a single injection of corticosteroid medication was associated with poorer outcomes after one year and higher recurrence rates compared with ...
Diseases, Conditions, Syndromes
Feb 05, 2013 |
not rated yet |
0
Pfizer disputes suit claiming Zoloft doesn't work
(AP)—The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill. The federal lawsuit, filed in California, argues that patients who took it should be reimbursed ...
Medications
Jan 31, 2013 |
1 / 5 (1) |
0
